NCT06758752Active, not recruitingPhase 2
A Herbal Compound for Eczema
Evaluation of Therapeutic Effects of ZAX.1400.EC.02 a Herbal Compound on Clinical Signs of Skin in Eczema Patients
Source: ClinicalTrials.gov · Last updated 6 Jan 2025
Brief summary (registry, in English)
The goal of this interventional clinical trial study is to compare ZAX.1400.EC.02 and placebo in Eczema patients. The main question it aims to answer is: • Can treatment with ZAX.1400.EC.02 for 3 weeks improve clinical signs of skin in Eczema patients? Participants will be divided into two groups. One group will use ZAX.1400.EC.02 topically twice daily for 3 weeks and the other group will use placebo topically twice daily for 3 weeks. Researchers will compare treatment and placebo groups to see if there is any improvement in the clinical signs of skin caused by Eczema after treatment with ZAX.1400.EC.02 for 3 weeks.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 110 (actual)
- First submitted
- 28 Dec 2024
- Start date
- 1 Oct 2023
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- Fasa University of Medical Sciences
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT06758752
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 110
- From 1 Oct 2023 to the primary completion date, 30 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Incidence of drug product allergy
- Occurrence of symptoms of skin, digestive, liver or kidney diseases
Other
- Non-consent of the doctor directly responsible for the patient
- Patients lack of consent to continue for any reason
Who the study is looking for
- Diagnosis of the disease by a doctor
- Age range between 18 and 60 years
- Both sexes (male and female)
- Having written informed consent to participate in the study
- Lack of allergy to food and health products
- Absence of underlying diseases and immune deficiency
- Absence of pregnancy and breastfeeding
- Absence of blisters and infection caused by the disease
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fasa university of medical sciences Coordinator of this site? Confirm its status | Fasa | Iran | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.